adenosine has been researched along with Acute Onset Vascular Dementia in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (75.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (25.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, X; Du, B; Du, Z; Fan, C; Jiang, Y; Li, H; Liang, M; Zhang, H; Zhang, Y | 1 |
| Rudolphi, KA; Schubert, P | 1 |
| Kittner, B; Rössner, M; Rother, M | 1 |
| Kapl, D; Rudolphi, KA | 1 |
3 review(s) available for adenosine and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
Modulation of neuronal and glial cell function by adenosine and neuroprotection in vascular dementia.
Topics: Adenosine; Animals; Dementia, Vascular; Humans; Neuroglia; Neurons; Neuroprotective Agents; Purinergic P1 Receptor Antagonists | 1997 |
Clinical trials in dementia with propentofylline.
Topics: Adenosine; Aged; Alzheimer Disease; Clinical Trials, Phase III as Topic; Dementia, Vascular; Double-Blind Method; Female; Humans; Male; Meta-Analysis as Topic; Neuroprotective Agents; Randomized Controlled Trials as Topic; Xanthines | 1997 |
[New pharmacologic aspects in the neurologic profile of propentofylline (Karsivan ad us. vet.)].
Topics: Adenosine; Alzheimer Disease; Animals; Cerebrovascular Circulation; Cognition Disorders; Dementia, Vascular; Dog Diseases; Dogs; Hemodynamics; Humans; Neuroprotective Agents; Phosphodiesterase Inhibitors; Xanthines | 1998 |
1 other study(ies) available for adenosine and Acute Onset Vascular Dementia
| Article | Year |
|---|---|
N6-methyladenosine (m6A) modification and its clinical relevance in cognitive dysfunctions.
Topics: Adenosine; Aged; Aged, 80 and over; Alzheimer Disease; Biomarkers; Brain; Cognition; Cognitive Dysfunction; Datasets as Topic; Dementia, Vascular; Female; Humans; Male; Methylation; Methyltransferases; RNA Processing, Post-Transcriptional; RNA, Messenger; snRNP Core Proteins | 2021 |